A phase 1 study of DS-8201a in combination with olaparib in HER2-expressing malignancies (CTEP #10355): Results of module 1 dose escalationElizabeth K. Lee,Andrea E. Wahner Hendrickson,Gerardo Colon-Otero, Cheryl A. Pickett,Niya Xiong,Su-Chun Cheng,Madeline Polak,Hannah Sawyer, Martin Hayes,Ursula A. Matulonis,Geoffrey I. Shapiro,Panagiotis A. KonstantinopoulosMOLECULAR CANCER THERAPEUTICS（2023）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
